Medical Management – Page 65 – Laopdr News Gazette

July 16, 20140

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

HONG KONG, July 16, 2014 /PRNewswire/ -- OrbusNeich today announced that the first patient has been enrolled in the Multinational Abluminal Sirolimus

July 16, 20140

New Reports From The Alzheimer’s Association International Conference® 2014 Show Progress In Early Detection, Identifying Risk Factors, And Treatment Trial Updates

COPENHAGEN, Denmark, July 16, 2014 /PRNewswire/ -- New studies reported at the Alzheimer's Association International Conference 2014 (AAIC® 2014)

July 16, 20140

BioSpain 2014 Expands its Investment Forum Through Wider Range of Investor Profiles and more Participating Companies

MADRID, July 16, 2014 /PRNewswire/ -- Biospain 2014 is currently seeking and selecting projects for presentation as part of its Investment Forum, one

July 15, 20140

Aptuit Names Dr. Paul Overton Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities

GREENWICH, Conn., July 16, 2014 /PRNewswire/ -- Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Category: Medical Management

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

New Reports From The Alzheimer’s Association International Conference® 2014 Show Progress In Early Detection, Identifying Risk Factors, And Treatment Trial Updates

BioSpain 2014 Expands its Investment Forum Through Wider Range of Investor Profiles and more Participating Companies

Aptuit Names Dr. Paul Overton Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities